BILL (NYSE:BILL) Rating Lowered to “Equal Weight” at Morgan Stanley
BILL (NYSE:BILL – Get Free Report) was downgraded by investment analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research note issued on Wednesday, Marketbeat.com reports. They presently have a $55.00 price objective on the stock, down from their previous price objective of $60.00. Morgan Stanley’s target price would […]
BILL (NYSE:BILL – Get Free Report) was downgraded by investment analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research note issued on Wednesday, Marketbeat.com reports. They presently have a $55.00 price objective on the stock, down from their previous price objective of $60.00. Morgan Stanley’s target price would […]
